This journal club will include presentation and discussion of the recently-published article "Dupilumab Versus Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma (EVEREST): A Multicentre, Randomised, Double-blind, Head-to-head Phase 4 Trial", which was published this month in the Lancet Respiratory Medicine. This Phase 4 trial is the first in the field to directly compare biologic therapies for CRSwNP and coexisting asthma, and we look forward to an engaging discussion.
Presenting will be lead author Eugenio De Corso, PhD, A Gemelli Hospital Foundation IRCCS, Rome, Italy.
We will also be joined by our expert discussants Ayobami Akenroye, MBChB, MPH, PhD, Brigham and Women's Hospital/Harvard Medical School, and Juan Carlos Cardet, MD, University of South Florida.